INSIGHTS ON LIQUID DOSE MANUFACTURING

• Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation

  Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.

• Agile Sterile Injectable Filling for Faster Market Entry

  CMOs specializing in sterile injectable filling help pharmaceutical companies speed up product development and commercialization through flexible manufacturing, adaptability, and strong collaboration.

• How DFM Promotes Scalability, Repeatability, And Profitability

  Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.

• Advanced Isolator Tech Boosts Manufacturing Efficiency And Quality

  Isolator technology can run continuously over several days, minimizing operator interaction and other opportunities to introduce contamination — ideal for high-volume, time-limited production runs.

• Benefits Of Isolator Technology In Fill-Finish

  12/10/2025

  Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

• Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer

  11/21/2024

  Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  4/20/2026

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Afton Scientific Capabilities Update January 2026: Fill/Finish

  1/27/2026

  Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

• Lifecycle Planning For Containment And Delivery Of Biologics Drug Products

  6/20/2024

  Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.